JP Morgan Chase’s Humacyte HUMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$46.5K Buy
80,932
+5,150
+7% +$5.35K ﹤0.01% 6235
2025
Q4
$72.8K Buy
75,782
+11,620
+18% +$16.5K ﹤0.01% 6066
2025
Q3
$112K Sell
64,162
-5,905
-8% -$11.6K ﹤0.01% 5840
2025
Q2
$146K Buy
70,067
+16,702
+31% +$32.1K ﹤0.01% 5417
2025
Q1
$91K Buy
53,365
+2,721
+5% +$10.2K ﹤0.01% 5617
2024
Q4
$256K Sell
50,644
-1,191
-2% -$5.89K ﹤0.01% 5370
2024
Q3
$282K Sell
51,835
-356
-0.7% -$2.35K ﹤0.01% 5239
2024
Q2
$251K Buy
52,191
+4,360
+9% +$22.7K ﹤0.01% 5041
2024
Q1
$149K Sell
47,831
-14,141
-23% -$47.6K ﹤0.01% 5498
2023
Q4
$176K Buy
61,972
+377
+0.6% +$968 ﹤0.01% 5461
2023
Q3
$180K Buy
61,595
+8,069
+15% +$26.7K ﹤0.01% 5125
2023
Q2
$153K Buy
53,526
+2,548
+5% +$9.19K ﹤0.01% 5242
2023
Q1
$157K Buy
50,978
+13,676
+37% +$38.9K ﹤0.01% 5201
2022
Q4
$79K Buy
37,302
+19,784
+113% +$60.1K ﹤0.01% 5442
2022
Q3
$58K Buy
17,518
+2,932
+20% +$11.2K ﹤0.01% 5496
2022
Q2
$47K Buy
14,586
+2,034
+16% +$11.3K ﹤0.01% 5677
2022
Q1
$89K Sell
12,552
-1,846
-13% -$10.7K ﹤0.01% 5563
2021
Q4
$105K Buy
+14,398
New +$142K ﹤0.01% 5658

Other funds holding HUMA